Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Dillon

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
Bone Marrow Transplantation|October 18, 2024
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemiaPranay S Hegde, Georgia Andrew, Gege Gui, et al.
Physiological Genomics|January 5, 2002
A compendium of gene expression in normal human tissuesL L Hsiao, F Dangond, T Yoshida, et al.
JCO Precision Oncology|May 26, 2021
Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic SyndromeLaura W Dillon, Gege Gui, Brent R Logan, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemiaMeghali Goswami, Gege Gui, Laura W Dillon, et al.
American Journal of Hematology|March 13, 2020
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effectsAnthony D Sung, Shekeab Jauhari, Sharareh Siamakpour-Reihani, et al.
Bone Marrow Transplantation|November 6, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 5, 2018
Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert PanelMelissa A Kelly, Colleen Caleshu, Ana Morales, et al.
Blood Cancer Discovery|July 14, 2021
Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal HematopoiesisLaura W Dillon, Jack Ghannam, Chidera Nosiri, et al.
JAMA Oncology|May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W Dillon, Gege Gui, Niveditha Ravindra, et al.
Blood|November 14, 2025
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18Steven Knapper, Laura W Dillon, Malavika Babu, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Bone Marrow Transplantation|October 18, 2024
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemiaPranay S Hegde, Georgia Andrew, Gege Gui, et al.
Physiological Genomics|January 5, 2002
A compendium of gene expression in normal human tissuesL L Hsiao, F Dangond, T Yoshida, et al.
JCO Precision Oncology|May 26, 2021
Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic SyndromeLaura W Dillon, Gege Gui, Brent R Logan, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemiaMeghali Goswami, Gege Gui, Laura W Dillon, et al.
American Journal of Hematology|March 13, 2020
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effectsAnthony D Sung, Shekeab Jauhari, Sharareh Siamakpour-Reihani, et al.
Bone Marrow Transplantation|November 6, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 5, 2018
Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert PanelMelissa A Kelly, Colleen Caleshu, Ana Morales, et al.
Blood Cancer Discovery|July 14, 2021
Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal HematopoiesisLaura W Dillon, Jack Ghannam, Chidera Nosiri, et al.
JAMA Oncology|May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W Dillon, Gege Gui, Niveditha Ravindra, et al.
Blood|November 14, 2025
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18Steven Knapper, Laura W Dillon, Malavika Babu, et al.
Pageof 19